Advancing Anticancer Drug Discovery: Leveraging Metabolomics and Machine Learning for Mode of Action Prediction by Pattern Recognition
Advanced Science · 2024-12 · 11 (47)
DOI: 10.1002/advs.202404085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 21.10.2024. Verfasst von Mohamad Saoud und 12 weiteren Autor:innen. Beteiligte Einrichtung: Leibniz Institute of Plant Biochemistry, Dept. of Bioorganic Chemistry, Weinberg 3, 06120, Halle (Saale), Germany. Hauptthemen laut MEDLINE: Metabolomics, Antineoplastic Agents, Machine Learning, Drug Discovery. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A bottleneck in the development of new anti‐cancer drugs is the recognition of their mode of action (MoA). Metabolomics combined with machine learning allowed to predict MoAs of novel anti‐proliferative drug candidates, focusing on human prostate cancer cells (PC‐3). As proof of concept, 38 drugs are studied with known effects on 16 key processes of cancer metabolism, profiling low molecular weight intermediates of the central carbon and cellular energy metabolism (CCEM) by LC‐MS/MS. These metabolic patterns unveiled distinct MoAs, enabling accurate MoA predictions for novel agents by machine learning. The transferability of MoA predictions based on PC‐3 cell treatments is validated with two other cancer cell models, i.e., breast cancer and Ewing's sarcoma, and show that correct MoA predictions for alternative cancer cells are possible, but still at some expense of prediction quality. Furthermore, metabolic profiles of treated cells yield insights into intracellular processes, exemplified for drugs inducing different types of mitochondrial dysfunction. Specifically, it is predicted that pentacyclic triterpenes inhibit oxidative phosphorylation and affect phospholipid biosynthesis, as confirmed by respiration parameters, lipidomics, and molecular docking. Using biochemical insights from individual drug treatments, this approach offers new opportunities, including the optimization of combinatorial drug applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leibniz Institute of Plant Biochemistry, Dept. of Bioorganic Chemistry, Weinberg 3, 06120, Halle (Saale), Germany.
- Martin Luther University Halle-Wittenberg, Institute of Computer Science, 06120, Halle (Saale), Germany.
- Martin Luther University Halle-Wittenberg, Medical Faculty, University Clinic for Internal Medicine IV (Hematology/Oncology), 06120, Halle (Saale), Germany.
- Leibniz Institute of Plant Biochemistry, Dept. of Cell and Metabolic Biology, Weinberg 3, 06120, Halle (Saale), Germany.
- Martin Luther University Halle-Wittenberg, Institute of Chemistry, Department of Organic and Bioorganic Chemistry, 06120, Halle (Saale), Germany.
- Dhofar University, Research Center, Frankincense Biodiversity Unit, Salalah, 211, Oman.
ORCID-Profile: Jan Grau, Gerd U Balcke
Zitieren
APA
Saoud, M., Grau, J., Rennert, R., Mueller, T., Yousefi, M., Davari, M. D., Hause, B., Csuk, R., Rashan, L., Grosse, I., Tissier, A., Wessjohann, L. A., & Balcke, G. U. (2024). Advancing Anticancer Drug Discovery: Leveraging Metabolomics and Machine Learning for Mode of Action Prediction by Pattern Recognition. Advanced Science, 11(47). https://doi.org/10.1002/advs.202404085
Vancouver
Saoud M, Grau J, Rennert R, Mueller T, Yousefi M, Davari MD, et al. Advancing Anticancer Drug Discovery: Leveraging Metabolomics and Machine Learning for Mode of Action Prediction by Pattern Recognition. Advanced Science. 2024;11(47). doi:10.1002/advs.202404085
BibTeX
@article{Saoud2024,
author = {Saoud, Mohamad and Grau, Jan and Rennert, Robert and Mueller, Thomas and Yousefi, Mohammad and Davari, Mehdi D and Hause, Bettina and Csuk, René and Rashan, Luay and Grosse, Ivo and Tissier, Alain and Wessjohann, Ludger A and Balcke, Gerd U},
title = {Advancing Anticancer Drug Discovery: Leveraging Metabolomics and Machine Learning for Mode of Action Prediction by Pattern Recognition},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {47},
doi = {10.1002/advs.202404085}
}
EUVIMED